Insider Sales at Sera Prognostics: Market Impact & FDA Clearance Outlook
Insightful analysis of Sera Prognostics insider sales, showing how recent 2,000‑share liquidation reflects leadership confidence and its impact on the company’s declining stock and promising cell‑based diagnostics pipeline.
4 minutes to read